Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Rituxan (rituximab) - Roche
Calquence (acalabrutinib) - AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT04688151
Sep 18, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next